News: Infectious Diseases

Read the latest news from the College of Natural Sciences at The University of Texas at Austin

Podcast

Experimental Vaccine Against Respiratory Syncytial Virus (RSV) Elicits Strong Immune Response

After decades of research, an effective RSV vaccine now seems within reach

A patient receives a vaccination in the arm

Research

Fighting Hepatitis C Virus, Using Clues from What Killed Bevo XIV

And other adventures in animal viruses teaching us about human disease

Image of Bevo with a handler standing beside him

Department of Molecular Biosciences

The 40 Year-old Discovery Behind A Promising New Flu Drug

How basic research led to a better antiviral drug to combat influenza

Robert Krug in his lab at Memorial Sloan-Kettering Cancer Center, circa 1970s.

Research

Promise of New Antibiotics Lies with Shackling Tiny Toxic Tetherballs to Bacteria

Bryan Davies of The University of Texas at Austin and a team have developed a system to identify new options for fighting bacteria.

Artist rendering of bacteria in orange on dark brown background

Research

Ancient Enzyme Could Boost Power of Liquid Biopsies to Detect and Profile Cancers

A set of medical tests called liquid biopsies could rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample.

Illustration of a person's circulatory system and the person is surrounded by bubbles of DNA

Research

Cracking the Code: Why Flu Pandemics Come At the End of Flu Season

Graduate student Spencer Fox and his colleagues found strong evidence that the late timing of flu pandemics is caused by two opposing factors.

Hypothetical seasonal flu epidemic spread (not based on real or simulated data) is depicted here

Features

Scientist Battling Invincible Microbes Takes Fight to the Silver Screen

Learn about UT Austin's Bryan Davies and his research into how to combat antibiotic-resistant bacteria and develop new antimicrobials to fight infection.

Two men embrace

Research

Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval

The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).

White bacterial coloines on a plate of red culture medium

Podcast

Jekyll and Hyde Bacteria

What do you do when the bacteria you study that's deadly in the real world acts all mild and gentle in the lab?

Microscope image of pink bacteria with hair-like and corkscrew-like structures